IRIDEX (IRIX) - 2023 Q3 - Earnings Call Transcript

The LCDs limit MIGS procedures concomitant with cataract surgery to a single device and specifically call out newer MIGS devices that enable both a canaloplasty and a goniotomy procedure to be performed with a single device. These and several other procedures were labeled as investigational, which means they were made ineligible for Medicare reimbursement until more rigorous clinical work on effectiveness is published. First, half of IRIDEX' glaucoma revenue is international and unaffected. Further, two of ...